This compound is a deuterated active pharmaceutical ingredient, specifically a deuterium-labeled analogue of a beta-adrenergic receptor agonist. The deuterium atoms are incorporated at the benzylic alcohol and hydroxymethyl positions, which may alter its metabolic profile for research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1219798-60-3
Tricyclo[3.3.1.13,7]decan-2,2,8,8,9,9-d6-1-amine
pharmaceutical raw material
(R)-(-)-Phenylephrine-d3 HCl
pharmaceutical raw material
Rac Naproxen-d3
pharmaceutical raw material
Alendronic acid-d6
pharmaceutical raw material
Metoprolol-D7 Hydrochloride
pharmaceutical raw material
(+/-)-Ondansetron-d5 (methylimidazole-d5)
pharmaceutical raw material
Donepezil-d4 (hydrochloride)
pharmaceutical raw material
HYDROCHLOROTHIAZIDE-3,3-D2
pharmaceutical raw material
4-[2-(tert-butylamino)-1-deuterio-1-hydroxyethyl]-2-[dideuterio(hydroxy)methyl]phenol
NDAUXUAQIAJITI-STOMFCJLSA-N
[2H]C([2H])(C1=C(C=CC(=C1)C([2H])(CNC(C)(C)C)O)O)O